Baduanjin Versus Brisk Walking for Cognition in Schizophrenia

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Enrolling

Conditions

Schizophrenia
Condition
Exercise

Treatments

Behavioral: Baduanjin exercsie
Behavioral: Health education
Behavioral: Brisk walking

Study type

Interventional

Funder types

Other

Identifiers

NCT06226779
202400006B0

Details and patient eligibility

About

The current study intends to recruit participants with schizophrenia for the practice of Baduanjin, brisk walking, and health education after enrollment. The study also including a maintenance program. Cognitive and physical function assessments will be conducted before, after, and during follow-up tests. The research hypothesis posits that both Baduanjin and brisk walking will confer beneficial effects on various aspects of cognitive and physical functions.

Full description

Cognitive function deficits are core features in patients with schizophrenia. These deficits need active intervention to prevent functional decline. Baduanjin and brisk walking show promise as interventions in patients with schizophrenia. This study investigated the effects of Baduanjin exercise versus brisk walking in patients with schizophrenia. This study will be a single-blind, 3-arm, parallel, randomized controlled trial. A total of 120 patients with schizophrenia will be enrolled and randomly assigned to the Baduanjin group, brisk walking group or control group. The intervention group will practice Badunjin exercise. While participants in brisk walking group will receive brisk walking at the same duration. The controls will watch videos that are not aimed at improving physical exertion. Maintenance programs will also be conducted for participants to encourage practicing in exercise after intervention. All group will undergo evaluation at three time points: baseline, immediately after intervention and 4-week follow up after intervention. The primary outcome will be cognitive function and physical function. Secondary outcomes will include mood, sleep quality, and quality of live.

Enrollment

120 estimated patients

Sex

All

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Having a diagnosis of schizophrenia according to the DSM-5.
  • Who will be above 20-65 years of age .
  • Having a stable mental status without shift in medication and keep in same dose for at least one month.
  • Being able to walk independently for 50 meters.

Exclusion criteria

  • Serious physical conditions that will impede participation, such as cardiovascular disease, musculoskeletal disease or pulmonary system disease.
  • Visual or auditory impairment that precludes completion of assessment.
  • Acute psychosis requiring hospitalization.
  • Presence of severe withdrawal or profound cognitive disability that cause difficulties in following instructions.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 3 patient groups

Baduanjin
Experimental group
Description:
Parcipants will practice baduanjin exercise.
Treatment:
Behavioral: Baduanjin exercsie
Brisk walking
Active Comparator group
Description:
Parcipants will perform brisk walking activities.
Treatment:
Behavioral: Brisk walking
health education
Other group
Description:
Parcipants will receive health education classes and watch sport related videos.
Treatment:
Behavioral: Health education

Trial contacts and locations

0

Loading...

Central trial contact

Chyi-Rong Chen, Master; Keh-chung Lin, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems